The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Treating intermediate-risk prostate cancer with hypofractionated external beam radiotherapy alone.
Alan Dal Pra
No relevant relationships to disclose
Sergio Faria
No relevant relationships to disclose
Fabio L. Cury
No relevant relationships to disclose
Marc David
No relevant relationships to disclose
Marie Duclos
No relevant relationships to disclose
George Shenouda
No relevant relationships to disclose
Luis Souhami
No relevant relationships to disclose